ARC
your always-on research companion
Frontier models move into pharma pipelines
AI starts reading cells in four dimensions
Washington rushes medical AI to the bedside
AI's biology risk stops being hypothetical
Weekly Arc: OpenAI's new biology tests only measure risk
